Increased Circulating Endothelial Apoptotic Microparticle to Endothelial Progenitor Cell Ratio Is Associated with Subsequent Decline in Glomerular Filtration Rate in Hypertensive Patients

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Hsu, Chien Yi ^a,b   Huang, Po Hsun ^a,b   Chiang, Chia Hung ^a,b   Leu, Hsin Bang ^a,b   Huang, Chin Chou ^a,b   Chen, Jaw Wen ^a,b   Lin, Shing Jong ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CD31 ANTIGEN; CD34 ANTIGEN; CREATININE; LIPOCORTIN 5; VASCULOTROPIN RECEPTOR 2;

ADULT; ALBUMIN URINE LEVEL; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE ASSOCIATION; ENDOTHELIAL APOPTOTIC MICROPARTICLE TO ENDOTHELIAL PROGENITOR CELL RATIO; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; FRAMINGHAM RISK SCORE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PATHOGENESIS; PROTEIN BLOOD LEVEL; RENAL SYSTEM PARAMETERS; RENOVASCULAR HYPERTENSION; RISK ASSESSMENT; RISK FACTOR; URINE LEVEL;

APOPTOSIS; CELL COUNT; CELL-DERIVED MICROPARTICLES; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; STEM CELLS;

EID: 84880067455     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068644     Document Type: Article

References (39)

1. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, et al. (2004) Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 15: 1307-15.
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY, (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-305.
3. Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, et al. (2002) The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39: 1113-9.
4. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S, (2001) Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134: 629-36.
5. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS, (2003) Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12.
6. Ruilope LM, Salvetti A, Jamerson K, Hansson L, Warnold I, et al. (2001) Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) Study. J Am Soc Nephrol 12: 218-25.
7. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, et al. (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351: 1285-95.
8. Zeiher AM, Drexler H, Wollschläger H, Just H, (1991) Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Circulation 84: 1984-92.
9. Bonetti PO, Lerman LO, Lerman A, (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23: 168-175.
10. Huang PH, Leu HB, Chen JW, Wu TC, Lu TM, et al. (2007) Decreased heparin cofactor II activity is associated with impaired endothelial function determined by brachial ultrasonography and predicts cardiovascular events. Int J Cardiol 114: 152-8.
11. Perticone F, Maio R, Tripepi G, Zoccali C, (2004) Endothelial dysfunction and mild renal insufficiency in essential hypertension. Circulation 110: 821-5.
12. Perticone F, Maio R, Perticone M, Sciacqua A, Shehaj E, et al. (2010) Endothelial dysfunction and subsequent decline in glomerular filtration rate in hypertensive patients. Circulation 122: 379-84.
13. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, et al. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600.
14. Sata M, (2003) Molecular strategies to treat vascular diseases: circulating vascular progenitor cell as a potential target for prophylactic treatment of atherosclerosis. Circ J. 67(12): 983-91.
15. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, et al. (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353: 999-1007.
16. França CN, Pinheiro LF, Izar MC, Brunialti MK, Salomão R, et al. (2012) Endothelial Progenitor Cell Mobilization and Platelet Microparticle Release Are Influenced by Clopidogrel Plasma Levels in Stable Coronary Artery Disease. Circ J. 76(3): 729-36.
17. Turan RG, Turan CH, Bozdag-Turan I, Ortak J, Akin I, et al. (2011) Impaired mobilization of CD133(+) bone marrow-derived circulating progenitor cells with an increased number of diseased coronary arteries in ischemic heart disease patients with diabetes. Circ J. 75(11): 2635-41.
18. Fujita Y, Asahara T, (2011) Evaluation of circulating endothelial progenitor cells in cardiovascular risk. Circ J. 75(11): 2541-2.
19. Horstman LL, Jy W, Jimenez JJ, Ahn YS, (2004) Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 9: 1118-35.
20. Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, et al. (2000) Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101: 841-3.
21. Werner N, Wassmann S, Ahlers P, Kosiol S, Nickenig G, (2006) Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 26: 112-6.
22. Pirro M, Schillaci G, Paltriccia R, Bagaglia F, Menecali C, et al. (2006) Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler Thromb Vasc Biol 26: 2530-5.
23. Amabile N, Guérin AP, Leroyer A, Mallat Z, Nguyen C, et al. (2005) Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 16: 3381-8.
24. Huang PH, Huang SS, Chen YH, Lin CP, Chiang KH, et al. (2010) Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria. J Hypertens 28: 1655-65.
25. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, et al. (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139: 137-47.
26. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-12.
27. Sabanayagam C, Wong TY, Tai ES, (2009) The CKD-EPI equation and MDRD study equation find similar prevalence of chronic kidney disease in Asian populations. Ann Intern Med 151: 892-3.
28. Liao Y, Liao W, Liu J, Xu G, Zeng R, (2011) Assessment of the CKD-EPI equation to estimate glomerular filtration rate in adults from a Chinese CKD population. J Int Med Res 39: 2273-80.
29. Chiang CH, Huang PH, Chung FP, Chen ZY, Leu HB, et al. (2012) Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease. PLoS One 7: 31799.
30. Sinning JM, Losch J, Walenta K, Böhm M, Nickenig G, et al. (2011) Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J 32: 2034-41.
31. Yun CH, Jung KH, Chu K, Kim SH, Ji KH, et al. (2010) Increased circulating endothelial microparticles and carotid atherosclerosis in obstructive sleep apnea. J Clin Neurol 6: 89-98.
32. Huang PH, Chen YH, Tsai HY, Chen JS, Wu TC, et al. (2010) Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability. Arterioscler Thromb Vasc Biol 30: 869-77.
33. Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, et al. (2004) The burden of kidney disease: improving global outcomes. Kidney Int 66: 1310-4.
34. Huang PH, Chen JW, Lu TM, Yu-An Ding P, Lin SJ, (2007) Combined use of endothelial function assessed by brachial ultrasound and high-sensitive C-reactive protein in predicting cardiovascular events. Clin Cardiol 30: 135-40.
35. Huang PH, Chen YH, Chen YL, Wu TC, Chen JW, et al. (2007) Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X. Heart. 93: 1064-70.
36. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, et al. (2001) Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104: 2649-2652.
37. Hristov M, Erl W, Linder S, Weber PC, (2004) Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro. Blood 104: 2761-2766.
38. Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L, (2010) Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int. 78(9): 838-848.
39. Cantaluppi V, Gatti S, Medica D, Figliolini F, Bruno S, et al. (2012) Microvesicles derived from endothelial progenitor cells protect kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of renal resident cells. Kidney Int. 82(4): 412-27.